These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19255329)

  • 1. Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia.
    Nowakowski GS; Hoyer JD; Shanafelt TD; Zent CS; Call TG; Bone ND; Laplant B; Dewald GW; Tschumper RC; Jelinek DF; Witzig TE; Kay NE
    J Clin Oncol; 2009 Apr; 27(11):1844-9. PubMed ID: 19255329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.
    Gogia A; Raina V; Gupta R; Gajendra S; Kumar L; Sharma A; Kumar R; Vishnubhatla S
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):514-7. PubMed ID: 24656596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test.
    Nowakowski GS; Hoyer JD; Shanafelt TD; Geyer SM; LaPlant BR; Call TG; Jelinek DF; Zent CS; Kay NE
    Mayo Clin Proc; 2007 Apr; 82(4):449-53. PubMed ID: 17418074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia.
    Johansson P; Eisele L; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J; Nückel H
    Leuk Res; 2010 Jul; 34(7):892-8. PubMed ID: 20353875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic value of smudge cells (Gumprecht shadows) in chronic lymphocytic leukaemia].
    Szerafin L; Jakó J; Riskó F; Hevessy Z
    Orv Hetil; 2012 Nov; 153(44):1732-7. PubMed ID: 23103742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated quantification of apoptosis in B-cell chronic lymphoproliferative disorders: a prognostic variable obtained with the Cell-Dyn Sapphire (Abbott) automated hematology analyzer.
    Fumi M; Martins D; Pancione Y; Sale S; Rocco V
    Int J Lab Hematol; 2014 Dec; 36(6):628-35. PubMed ID: 24888697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia and prognostic factors.
    Mozaheb Z; Hasanzadeh NazarAbadi MH; Aghaee MA
    Asian Pac J Cancer Prev; 2012; 13(7):3009-13. PubMed ID: 22994703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smudge cells percentage on blood smear is a reliable prognostic marker in chronic lymphocytic leukemia.
    Sall A; Seck M; Fall S; Sall FB; Faye BF; Ndiaye FS; Gadji M; Diop S; Touré AO; Raphaël M
    Hematol Transfus Cell Ther; 2022; 44(1):63-69. PubMed ID: 34116931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smudge cells, serum albumin, and prognosis in B-cell chronic lymphocytic leukemia.
    Go RS
    J Clin Oncol; 2009 Aug; 27(22):e44; author reply e45. PubMed ID: 19581530
    [No Abstract]   [Full Text] [Related]  

  • 10. Smudge cell percentage as a surrogate marker for ZAP-70 expression in patients with chronic lymphocytic leukemia.
    Al-Kahiry W; Tawfik HS; Sharshira H; Ghanem A; El-Gammal M; Mikhael IL
    Blood Res; 2018 Sep; 53(3):218-222. PubMed ID: 30310788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.
    Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Maddocks K; Jenkins G; Jelinek DF; Morice WG; Boysen J; Schwager S; Bowen D; Slager SL; Hanson CA
    J Clin Oncol; 2009 Aug; 27(24):3959-63. PubMed ID: 19620484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Counting Smudge Cells as Lymphocytes in Differential Leukocyte Counts Performed on Blood Smears of Patients With Established or Suspected Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Gulati G; Ly V; Uppal G; Gong J
    Lab Med; 2017 May; 48(2):137-147. PubMed ID: 28371883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival.
    Rizzo D; Lotay A; Gachard N; Marfak I; Faucher JL; Trimoreau F; Guérin E; Bordessoule D; Jaccard A; Feuillard J
    Am J Hematol; 2013 Sep; 88(9):747-53. PubMed ID: 23733486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Smudge Cells in Peripheral Blood Smears in Hematological Malignancies and Other Diseases.
    Chang CC; Sun JT; Liou TH; Kuo CF; Bei CH; Lin SJ; Tsai WT; Tan NC; Liou CB; Su MJ; Yen TH; Chu FY
    Asian Pac J Cancer Prev; 2016; 17(4):1847-50. PubMed ID: 27221863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
    Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
    Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
    Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
    Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
    Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.
    Gentile M; Mauro FR; Calabrese E; De Propris MS; Giammartini E; Mancini F; Milani ML; Guarini A; Foà R
    Br J Haematol; 2005 Aug; 130(4):549-57. PubMed ID: 16098069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.